Drug
SD-809
SD-809 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
83%(5 trials)
Phase Distribution
Ph phase_2
1
17%
Ph phase_1
1
17%
Ph phase_3
4
67%
Phase Distribution
1
Early Stage
1
Mid Stage
4
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
4(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 34 (66.7%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_3
Reducing Involuntary Movements in Participants With Tardive Dyskinesia
NCT02198794
completedphase_3
Alternatives for Reducing Chorea in Huntington Disease
NCT01897896
completedphase_3
Addressing Involuntary Movements in Tardive Dyskinesia
NCT02291861
completedphase_1
A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)
NCT02674321
completedphase_2
Aim to Reduce Movements in Tardive Dyskinesia
NCT02195700
Clinical Trials (6)
Showing 6 of 6 trials
NCT02198794Phase 3
Reducing Involuntary Movements in Participants With Tardive Dyskinesia
NCT01897896Phase 3
Alternatives for Reducing Chorea in Huntington Disease
NCT02291861Phase 3
Addressing Involuntary Movements in Tardive Dyskinesia
NCT02674321Phase 1
A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)
NCT02195700Phase 2
Aim to Reduce Movements in Tardive Dyskinesia
NCT01795859Phase 3
First Time Use of SD-809 in Huntington Disease
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6